Work

A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer

Year: 2010

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-009-9383-9

Authors: Qing Zhou, Daniel Gustafson, Sujatha Nallapareddy, Sami Diab, Stephen Leong, Karl Lewis, Lia Gore, Wells A. Messersmith, Anthony M. Treston, S. Gail Eckhardt, Carolyn Sidor, D. Ross Camidge

Institutions: Guangdong General Hospital, Guangdong Academy of Medical Sciences, University of Colorado Anschutz, Colorado State University, CASI Pharmaceuticals (United States), University of Colorado Cancer Center

Language: English

Topic: Estrogen and related hormone effects

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Colorado State University, National Cancer Institute

Award: University of Colorado Cancer Center Support Grant

OpenAlex ID: W1963995164

FWCI: 3.594

Cites: 14

Cited by: 49

Related to: 10